654 related articles for article (PubMed ID: 14707058)
1. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
[TBL] [Abstract][Full Text] [Related]
2. Through regulation of TCR expression levels, an Idd7 region gene(s) interactively contributes to the impaired thymic deletion of autoreactive diabetogenic CD8+ T cells in nonobese diabetic mice.
Serreze DV; Choisy-Rossi CM; Grier AE; Holl TM; Chapman HD; Gahagan JR; Osborne MA; Zhang W; King BL; Brown A; Roopenian D; Marron MP
J Immunol; 2008 Mar; 180(5):3250-9. PubMed ID: 18292549
[TBL] [Abstract][Full Text] [Related]
3. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
Kanagawa O; Shimizu J; Vaupel BA
J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
[TBL] [Abstract][Full Text] [Related]
4. Enhanced pathogenicity of diabetogenic T cells escaping a non-MHC gene-controlled near death experience.
Choisy-Rossi CM; Holl TM; Pierce MA; Chapman HD; Serreze DV
J Immunol; 2004 Sep; 173(6):3791-800. PubMed ID: 15356126
[TBL] [Abstract][Full Text] [Related]
5. In a transgenic model of spontaneous autoimmune diabetes, expression of a protective class II MHC molecule results in thymic deletion of diabetogenic CD8+ T cells.
Morgan DJ; Nugent CT; Raveney BJ; Sherman LA
J Immunol; 2004 Jan; 172(2):1000-8. PubMed ID: 14707073
[TBL] [Abstract][Full Text] [Related]
6. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes.
Takaki T; Marron MP; Mathews CE; Guttmann ST; Bottino R; Trucco M; DiLorenzo TP; Serreze DV
J Immunol; 2006 Mar; 176(5):3257-65. PubMed ID: 16493087
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response.
Ridgway WM; Ito H; Fassò M; Yu C; Fathman CG
J Exp Med; 1998 Dec; 188(12):2267-75. PubMed ID: 9858513
[TBL] [Abstract][Full Text] [Related]
8. B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice.
Silveira PA; Dombrowsky J; Johnson E; Chapman HD; Nemazee D; Serreze DV
J Immunol; 2004 Apr; 172(8):5086-94. PubMed ID: 15067092
[TBL] [Abstract][Full Text] [Related]
9. Requirement for both H-2Db and H-2Kd for the induction of diabetes by the promiscuous CD8+ T cell clonotype AI4.
Takaki T; Lieberman SM; Holl TM; Han B; Santamaria P; Serreze DV; DiLorenzo TP
J Immunol; 2004 Aug; 173(4):2530-41. PubMed ID: 15294969
[TBL] [Abstract][Full Text] [Related]
10. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions.
Graser RT; DiLorenzo TP; Wang F; Christianson GJ; Chapman HD; Roopenian DC; Nathenson SG; Serreze DV
J Immunol; 2000 Apr; 164(7):3913-8. PubMed ID: 10725754
[TBL] [Abstract][Full Text] [Related]
11. Cross-positive selection of thymocytes expressing a single TCR by multiple major histocompatibility complex molecules of both classes: implications for CD4+ versus CD8+ lineage commitment.
Eshima K; Suzuki H; Shinohara N
J Immunol; 2006 Feb; 176(3):1628-36. PubMed ID: 16424192
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of autoimmune diabetes in nonobese diabetic mice by transgenic restoration of H2-E MHC class II expression: additive, but unequal, involvement of multiple APC subtypes.
Johnson EA; Silveira P; Chapman HD; Leiter EH; Serreze DV
J Immunol; 2001 Aug; 167(4):2404-10. PubMed ID: 11490031
[TBL] [Abstract][Full Text] [Related]
13. Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.
Ranheim EA; Tarbell KV; Krogsgaard M; Mallet-Designe V; Teyton L; McDevitt HO; Weissman IL
Autoimmunity; 2004 Dec; 37(8):555-67. PubMed ID: 15763918
[TBL] [Abstract][Full Text] [Related]
14. A Hypermorphic
Presa M; Racine JJ; Dwyer JR; Lamont DJ; Ratiu JJ; Sarsani VK; Chen YG; Geurts A; Schmitz I; Stearns T; Allocco J; Chapman HD; Serreze DV
J Immunol; 2018 Oct; 201(7):1907-1917. PubMed ID: 30127089
[TBL] [Abstract][Full Text] [Related]
15. Idd9/11 genetic locus regulates diabetogenic activity of CD4 T-cells in nonobese diabetic (NOD) mice.
Chen YG; Scheuplein F; Osborne MA; Tsaih SW; Chapman HD; Serreze DV
Diabetes; 2008 Dec; 57(12):3273-80. PubMed ID: 18776136
[TBL] [Abstract][Full Text] [Related]
16. Antidiabetogenic MHC class II promotes the differentiation of MHC-promiscuous autoreactive T cells into FOXP3+ regulatory T cells.
Tsai S; Serra P; Clemente-Casares X; Yamanouchi J; Thiessen S; Slattery RM; Elliott JF; Santamaria P
Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3471-6. PubMed ID: 23401506
[TBL] [Abstract][Full Text] [Related]
17. Cellular expression requirements for inhibition of type 1 diabetes by a dominantly protective major histocompatibility complex haplotype.
Chen YG; Silveira PA; Osborne MA; Chapman HD; Serreze DV
Diabetes; 2007 Feb; 56(2):424-30. PubMed ID: 17259387
[TBL] [Abstract][Full Text] [Related]
18. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
Kupfer TM; Crawford ML; Pham K; Gill RG
J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
[TBL] [Abstract][Full Text] [Related]
19. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity.
Schmidt D; Verdaguer J; Averill N; Santamaria P
J Exp Med; 1997 Oct; 186(7):1059-75. PubMed ID: 9314555
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
Mora C; Wong FS; Chang CH; Flavell RA
J Immunol; 1999 Apr; 162(8):4576-88. PubMed ID: 10201997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
